Premium
BRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN A REAL WORLD SETTING: CLINICAL OUTCOMES AND IMPACT ON QUALITY OF LIFE
Author(s) -
Ionova T.,
Andrievskikh M.,
Amdiev A.,
Baryakh E.,
Chang V.,
Endakova A.,
Fadeeva N.,
Husainova G.,
Ivanov V.,
Kaplanov K.,
Kaverina O.,
Kiseleva M.,
Klitochenko T.,
Kurakin V.,
Larionova O.,
Lazareva D.,
Lepik K.,
Lysenko I.,
Melnichenko V.,
Mikhailova N.,
Minullina R.,
Mironov O.,
Misyurina E.,
Mochkin N.,
Nikitina T.,
Osipov Y.,
Petrova T.,
Porfirieva N.,
Rukavitsyn O.,
Safin R.,
Samoylova A.,
Shelekhova T.,
Sherstnev D.,
Simashova P.,
Smirnova E.,
Treni.,
Vasiliev E.,
Volodicheva E.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.67_2881
Subject(s) - brentuximab vedotin , medicine , quality of life (healthcare) , oncology , hodgkin lymphoma , surgery , lymphoma , nursing